Compounded semaglutide is semaglutide with an altered formula to create an unbranded alternative to Wegovy and Ozempic.

But there’s more we can learn from the data than simply how many users log on to the platforms from different countries. The ...

When you think of health care, what do you picture? Many of us see doctors in white coats and nurses wearing scrubs, but we don’t think of the people behind the scenes who ensure everything runs ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs ...

If you have early climax (PE), you may have heard that selective serotonin reuptake inhibitors (SSRIs) and topical creams and ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Shares in Hims & Hers Health fell after the U.S. Food and Drug Administration said Eli Lilly's obesity and diabetes drugs are no longer in shortage. Shares were down 7% in premarket trading to $17.64.

Anticipating a 35% CAGR in 2025, Hims & Hers is poised for substantial growth. Read why I maintain my strong buy rating on ...

The Aam Aadmi Party (AAP) accuses corrupt officials of sabotaging the digitization of payments in the Delhi health sector by promoting a flawed hospital information management system (HIMS), impacting ...